(Q42512469)

1 November 2017

title

Comparison of molecular subtyping with BluePrint, MammaPrint, and TargetPrint to local clinical subtyping in breast cancer patients (English)

1 reference

1 November 2017

Bichlien Nguyen

1

1 reference

1 November 2017

Pino G Cusumano

2

1 reference

1 November 2017

Kenneth Deck

3

1 reference

1 November 2017

Deborah Kerlin

4

1 reference

1 November 2017

Agustin A Garcia

5

1 reference

1 November 2017

Julie L Barone

6

1 reference

1 November 2017

Edgardo Rivera

7

1 reference

1 November 2017

Katharine Yao

8

1 reference

1 November 2017

Femke A de Snoo

9

1 reference

1 November 2017

Jeroen van den Akker

10

1 reference

1 November 2017

Lisette Stork-Sloots

11

1 reference

1 November 2017

Daniele Generali

12

1 reference

1 November 2017

publication date

15 August 2012

1 reference

Annals of Surgical Oncology

1 November 2017

published in

1 reference

1 November 2017

volume

19

1 reference

1 November 2017

issue

10

1 reference

1 November 2017

page(s)

3257-3263

1 reference

Molecular portraits of human breast tumours

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2561-6

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2561-6

The effects of fixation, processing and evaluation criteria on immunohistochemical detection of hormone receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2561-6

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2561-6

A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2561-6

Gene-expression signatures in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2561-6

A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2561-6

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2561-6

Microarray-based determination of estrogen receptor, progesterone receptor, and HER2 receptor status in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2561-6

Converting a breast cancer microarray signature into a high-throughput diagnostic test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2561-6

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2561-6

Comparison of MammaPrint and TargetPrint results with clinical parameters in German patients with early stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2561-6

10.1245/S10434-012-2561-6

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

1 November 2017

1016994220

0 references

1 reference